Dmitry V Cheboksarov¹* and Olga V Ryzhova²

¹PHD, Senior Researcher, FGBNU "FNCC RR", Moscow, Russia
²Medical Rehabilitation Doctor FGBNU "FNCC RR", Moscow, Russia

*Corresponding Author: Dmitry V Cheboksarov, PHD, Senior Researcher, FGBNU "FNCC RR", Moscow, Russia.

Received: May 29, 2023; Published: July 07, 2023

Abstract

Therapeutic hypothermia (TH), as the main method of targeted temperature management (TTM), consists of the use of neurovegetative blockades and general cooling of the body. TTM has been widely used in clinical practice since the mid-twentieth century thanks to the work of the scientific school of Bigelow, Rozomoff, Safar, and their followers.

The use of the TTM method significantly improved the effectiveness of shock therapy, significantly increasing the period of reversible changes in the central nervous system (CNS) during total ischemia and reducing the neurological consequences of neurotrauma. This led to its widespread use in intensive care, cardio- and neurosurgery, and traumatic brain injury treatment. The large volume of experimental and clinical studies performed allows us to reasonably consider TTM as a neuroprotection method that has a positive effect on most of the key mechanisms of secondary neuron damage.

Thus, the depression of metabolism in cells due to hypothermia is considered an important component of the neuroprotective effect of TTM. Reducing the need for oxygen and ATP helps to reduce the reactions of neurons to ischemia and lengthen the period of their life in hypoperfusion. Restriction of local inflammation in ACA and neurotrauma during hypothermia is accompanied by a decrease in leukocyte migration and infiltration of brain tissue by them, decreased edema, and decreased ICP. TTM reduces the amount of damage to the nervous tissue and neuronal death.

In this article, we propose our own TTM protocol based on our own and international experience of conducting hypothermia.

 Keywords: Therapeutic Hypothermia (TH); Targeted Temperature Management (TTM); Stroke; CPR

References

1. Bigelow WG and McBirnie JE. “Further experiences with hypothermia for intracardiac surgery in monkeys and groundhogs”. Annals of Surgery3 (1953): 361-365.
2. Rosomoff H L and Holaday D A. “Cerebral blood flow and cerebral oxygen consumption during hypothermia”. The American Journal of Physiology1 (1954): 85-88.
3. Safar P. “Community-wide cardiopulmonary resuscitation”. Journal of the Iowa Medical Society 54 (1964): 629-635.
4. Therapeutic Hypothermia After Cardiac Arrest. Clinical Application and Management Justin B. Lundbye Editor Springer, London, (2012): 122
5. Hoesch RE., et al. “Coma after global ischemic brain injure: pathophysiology and emerging therapies”. Critical Care Clinic 24 (2008): 25-44.
6. Wong CH and Crakc PJ. “Modulation of neuroinflammation and vascular response by oxidative stress following cerebral ischemia-reperfusion injury”. Current Medicinal Chemistry 15 (2008): 1-14
7. Brennan AM., et al. “NADPH oxidase ist he primary source of superoxide by NMDA receptor activation”. Nature Neuroscience 12 (2009): 857-863.
8. Eldadah BA and Faden AI. “Caspase pathways, neuronal apoptosis, and CNS injury”. Journal of Neurotrauma 17 (2000): 811-829.
9. Azmoon S., et al. “Neurologic and cardiac benefits of therapeutic hypothermia”. Cardiology Review 19 (2011): 108-114.
10. Mirto N PrandiniI., et al. “Mild hypothermia reduces polymorphonuclear leukocytes infiltration in induced brain inflammation”. Arquivos de Neuro-Psiquiatria3b (2005).
11. Bernard SA and Buist M. “Induced hypothermia in critical care medicine: a review”. Critical Care Medicine 31 (2003): 2041-2051.
12. Polderman KH. “Mechanisms of action, physiological effects, and complications of hypothermia”. Critical Care Medicine 37 (2009): 186-202.
13. Osborn JJ. “Experimental hypothermia; respiratory and blood pH changes in relation to cardiac function”. The American Journal of Physiology3 (1953): 389-398.
14. Polderman KH., et al. “Hypophosphatemia and hypomagnesemia induced by cooling in patients with severe head injury”. Journal of Neurosurgery5 (2001): 697-705.
15. Bernard SA., et al. “Rapid Infusion of Cold Hartmanns (RICH) Investigators. Induction of therapeutic hypothermia by paramedics after resuscitation from out-of-hospital ventricular fibrillation cardiac arrest: a randomized controlled trial”. Circulation7 (2010): 737-742.
16. Tortorici MA., et al. “Effects of hypothermia on drug disposition, metabolism, and response: A focus of hypothermia-mediated alterations on the cytochrome P450 enzyme system”. Critical Care Medicine9 (2007): 2196-2204.
17. Царев АВ. “Выраженность холодовой дрожи при развитии послеоперационной непреднамеренной гипотермии”. Актуальні проблеми сучасної медицини: Вісник української медичної стоматологічної академії. 1.61 (2018).
18. Rincon F., et al. “Association between hyperoxia and mortality after stroke: a multicenter cohort study”. Critical Care Medicine2 (2014): 387-396.

Citation

Citation: Dmitry V Cheboksarov and Olga V Ryzhova. “Protocol Targeted Temperature Management”.Acta Scientific Medical Sciences 7.8 (2023): 59-67.

Copyright

Copyright: © 2023 Dmitry V Cheboksarov and Olga V Ryzhova. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.